Gastrointestinal Therapeutics and Diagnostics Technology and Global Markets Report 2024: Revenue Data 2020-2022, Estimates for 2023, Forecasts for 2024, and CAGR Projections through 2028
April 04, 2024 06:29 ET
|
Research and Markets
Dublin, April 04, 2024 (GLOBE NEWSWIRE) -- The "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.The Global...
Global Gastroesophageal Reflux Disease Therapeutics Market Report 2023: Rising Prevalence of GERD and Other Gastrointestinal Disorders Drives Growth
May 16, 2023 11:13 ET
|
Research and Markets
Dublin, May 16, 2023 (GLOBE NEWSWIRE) -- The "Gastroesophageal Reflux Disease Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (Antacids, Proton Pump Inhibitors, H2 Receptor...
Global Antacids Market Analysis Report 2022: A $10.5 Billion Industry by 2027 Featuring Pfizer, GlaxoSmithKline, Dr Reddy's, Johnson & Johnson, Bayer, Sanofi, & Abbott Laboratories
February 15, 2023 03:08 ET
|
Research and Markets
Dublin, Feb. 15, 2023 (GLOBE NEWSWIRE) -- The "Antacids Market, Size, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis" report has been added to ...
Global Gastrointestinal Therapeutics Market Report 2022: Robust Product Development Presents Opportunities
January 30, 2023 05:23 ET
|
Research and Markets
Dublin, Jan. 30, 2023 (GLOBE NEWSWIRE) -- The "Global Gastrointestinal Therapeutics Market Size, Share & Industry Trends Analysis Report By Type, By Distribution Channel, By Route of...
Global Gastro Esophageal Reflux Disease Drug Market to 2027 - Featuring GlaxoSmithKline, Medtronic and Novartis Among Others
April 29, 2022 07:08 ET
|
Research and Markets
Dublin, April 29, 2022 (GLOBE NEWSWIRE) -- The "Global Gastro Esophageal Reflux Disease (GERD) Drug Market 2021-2027" report has been added to ResearchAndMarkets.com's offering. The global Gastro...
Global Eosinophilic Esophagitis Market Size to Surpass US$ 1,037.2 Million by 2028, Says Coherent Market Insights (CMI)
February 09, 2022 09:15 ET
|
CMI
SEATTLE, Feb. 09, 2022 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global eosinophilic esophagitis market is estimated to be valued at US$ 138.4 million in 2021 and is expected to...
Woodward Pharma Services LLC Acquires AcipHex Delayed-Release Tablets
November 01, 2021 09:00 ET
|
Woodward Pharma
WIXOM, Mich., Nov. 01, 2021 (GLOBE NEWSWIRE) -- Woodward Pharma Services LLC ("Woodward"), a Michigan-based specialty pharmaceutical company focused on acquiring, licensing and commercializing...
Global Gastroesophageal Reflux Disease Therapeutics Market (2021 to 2026) - by Drug Type, Distribution Channel and Region
September 10, 2021 06:13 ET
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Global Gastroesophageal Reflux Disease (GERD) Therapeutics Market - Analysis By Drug Type, Distribution Channel, By Region, and By Country (2021...
Global $3.97 Billion Antacids Markets, 2015-2020, 2020-2025F, 2030F
June 30, 2021 04:08 ET
|
Research and Markets
Dublin, June 30, 2021 (GLOBE NEWSWIRE) -- The "Antacids Global Market Report 2021: COVID-19 Impact and Recovery to 2030" report has been added to ResearchAndMarkets.com's offering. Major players in...
Global Antacids Market (2021 to 2026) - by Drug Class, Formulation, Distribution Channel and Geography
June 25, 2021 05:48 ET
|
Research and Markets
Dublin, June 25, 2021 (GLOBE NEWSWIRE) -- The "Global Antacids Market (2021-2026), by Drug Class, Formulation, Distribution Channel, Geography and the Impact of COVID-19 with Ansoff Analysis" report...